Drug information for OMNITROPE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 1.5MG/VIAL Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone SANDOZ 21426
2011-07-27 Letter

2011-07-25 Label

2011-04-15 Letter

2011-04-15 Label

2010-08-31 Letter

2010-08-27 Label

2010-05-03 Label

2010-05-03 Label

2010-04-28 Letter

2010-04-28 Letter

2009-03-27 Letter

2009-03-26 Label

2008-08-26 Label

2008-08-25 Letter

2008-01-18 Label

2008-01-18 Letter

2007-06-11 Review

2006-06-01 Letter

2006-05-31 Label
INJECTABLE; INJECTION 10MG/1.5ML Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone SANDOZ   "
INJECTABLE; INJECTION 5.8MG/VIAL Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone SANDOZ   "
INJECTABLE; INJECTION 5MG/1.5ML Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone SANDOZ   "

Drug Adverse Effects information for OMNITROPE

Role code Indications Reaction # Reports
PS DWARFISM RASH 1
PS DWARFISM URTICARIA 1
PS GROWTH HORMONE DEFICIENCY BENIGN INTRACRANIAL HYPERTENSION 1
PS GROWTH HORMONE DEFICIENCY CEREBELLAR INFARCTION 1
PS GROWTH HORMONE DEFICIENCY CEREBROVASCULAR ACCIDENT 1
PS GROWTH HORMONE DEFICIENCY HEADACHE 1
PS GROWTH HORMONE DEFICIENCY MUSCULOSKELETAL STIFFNESS 1
PS GROWTH HORMONE DEFICIENCY PAPILLOEDEMA 1
PS HYPOTHALAMO-PITUITARY DISORDER RASH 1
PS HYPOTHALAMO-PITUITARY DISORDER URTICARIA 1
PS MICROSOMIA ARTHRALGIA 1
PS MICROSOMIA BONE MARROW OEDEMA 1
SS DWARFISM HORMONE LEVEL ABNORMAL 3
SS DWARFISM HYPERSENSITIVITY 3
SS THYROID DISORDER HORMONE LEVEL ABNORMAL 1
SS THYROID DISORDER HYPERSENSITIVITY 1
C PRECOCIOUS PUBERTY FAT NECROSIS 2
C PRECOCIOUS PUBERTY IMPAIRED HEALING 2
C PRECOCIOUS PUBERTY INJECTION SITE ABSCESS 2
C PRECOCIOUS PUBERTY INJECTION SITE DISCHARGE 2
C PRECOCIOUS PUBERTY INJECTION SITE ERYTHEMA 2
C PRECOCIOUS PUBERTY INJECTION SITE INDURATION 2
C PRECOCIOUS PUBERTY WOUND 2
C PRODUCT USED FOR UNKNOWN INDICATION FAT NECROSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION IMPAIRED HEALING 1
C PRODUCT USED FOR UNKNOWN INDICATION INJECTION SITE ABSCESS 1
C PRODUCT USED FOR UNKNOWN INDICATION INJECTION SITE DISCHARGE 1
C PRODUCT USED FOR UNKNOWN INDICATION INJECTION SITE ERYTHEMA 1
C PRODUCT USED FOR UNKNOWN INDICATION INJECTION SITE INDURATION 1
C PRODUCT USED FOR UNKNOWN INDICATION WOUND 1
Ads by Google